Skip to main content
. 2016 May 24;7:202. doi: 10.3389/fimmu.2016.00202

Table 4.

Distribution of the studied alleles in ovarian cancer patients and healthy controls.

Gene Group
OR (95% CI)
Cases
Controls
No % No %
HLA-DP rs3077
 • AA 58 96.7 8 40.0 43.5 (8.2–57.3)*
 • AG 2 3.3 12 60.0 1
HLA-DQ rs3920
 • AG 20 33.3 15 75.0 1
 • GG 40 66.7 5 25.0 6.0 (1.9–18.8)*
ICAM-1 rs1437
 • CC 16 26.7 0 0.0 25.0 (1.4–125.6)*
 • CT 28 46.7 8 40.0 2.6 (1.0–7.8)*
 • TT 16 26.7 12 60.0 1

OR, odds ratio; CI, confidence interval.

*Significant (P < 0.05).